Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models

Indirect response (IDR) models have been widely applied to pharmacodynamic (PD) modeling, particularly when delayed response (hysteresis) is present. This paper proposes a class of nonlinear discrete-time autoregressive (AR) models with drug concentrations acting as a time-varying covariate on the asymptote parameter or the autocorrelation parameter of the AR models as an alternative modeling approach for delayed response data. The mathematical derivations revealed the inherent connection between IDR models and nonlinear AR models, and showed that the nonlinear AR models approximate the IDR models when the time interval between response data is small. Simulations demonstrate that the IDR models and the corresponding AR models produce similar temporal response profiles, and as the time interval decreased (i.e., more intensive sampling designs), the AR model based parameter estimates were more comparable to those estimated from the IDR models. In conjunction with mixed-effects modeling, the nonlinear AR models have been shown to well describe a set of simulated longitudinal PK/PD data for a clinical study. Further extensions of the proposed nonlinear AR models are warranted to model irregular and sparse PK/PD data.

[1]  State Space Representation of an Autoregressive Linear Mixed Effects Model for the Analysis of Longitudinal Data , 2008 .

[2]  William J. Jusko,et al.  Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus , 2008, Clinical pharmacokinetics.

[3]  M. A. Plant Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality , 1991 .

[4]  Johan Gabrielsson,et al.  Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications , 2002 .

[5]  Arnold Neumaier,et al.  Introduction to Numerical Analysis , 2001 .

[6]  M. Feinleib,et al.  Statistical Models for Longitudinal Studies of Health , 1992 .

[7]  James W T Yates Mathematical properties and parameter estimation for transit compartment pharmacodynamic models. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Varun Garg,et al.  Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[9]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[10]  P. Diggle,et al.  Analysis of Longitudinal Data , 2003 .

[12]  W. Jusko,et al.  Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. , 1998, The Journal of pharmacology and experimental therapeutics.

[13]  Mathematical Assessment of Properties of Precursor-Dependent Indirect Pharmacodynamic Response Models , 2006, Journal of Pharmacokinetics and Pharmacodynamics.

[14]  W J Jusko,et al.  Physiologic indirect response models characterize diverse types of pharmacodynamic effects , 1994, Clinical pharmacology and therapeutics.

[15]  W. Jusko,et al.  Mathematical Formalism for the Properties of Four Basic Models of Indirect Pharmacodynamic Responses , 1997, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[17]  R. Ramakrishnan,et al.  Basic Pharmacodynamic Models for Agents That Alter Production of Natural Cells , 1999, Journal of Pharmacokinetics and Biopharmaceutics.

[18]  F. Speizer,et al.  The use of an autoregressive model for the analysis of longitudinal data in epidemiologic studies. , 1985, Statistics in medicine.

[19]  W. Jusko,et al.  Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers , 2008, Journal of clinical pharmacology.

[20]  M O Karlsson,et al.  Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure. , 2001, British journal of clinical pharmacology.

[21]  J. Lindsey Models for Repeated Measurements , 1993 .

[22]  C H Schmid,et al.  Marginal and dynamic regression models for longitudinal data , 2001, Statistics in medicine.

[23]  B Rosner,et al.  Autoregressive modelling for the analysis of longitudinal data with unequally spaced examinations. , 1988, Statistics in medicine.

[24]  Wojciech Krzyzanski,et al.  Indirect Pharmacodynamic Models for Responses with Multicompartmental Distribution or Polyexponential Disposition , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[25]  Y. Ohashi,et al.  An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotes , 2007, Statistics in medicine.

[26]  W. Jusko,et al.  ALGORITHM FOR APPLICATION OF FOURIER ANALYSIS FOR BIORHYTHMIC BASELINES OF PHARMACODYNAMIC INDIRECT RESPONSE MODELS , 2000, Chronobiology international.

[27]  Hulin Wu,et al.  Mixed‐Effects State‐Space Models for Analysis of Longitudinal Dynamic Systems , 2011, Biometrics.

[28]  W J Jusko,et al.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. , 1998, Journal of pharmaceutical sciences.

[29]  Christopher H. Schmid An EM Algorithm Fitting First-Order Conditional Autoregressive Models to Longitudinal Data , 1996 .

[30]  W J Jusko,et al.  Characteristics of indirect pharmacodynamic models and applications to clinical drug responses. , 1998, British journal of clinical pharmacology.

[31]  Mats O. Karlsson,et al.  Approaches to handling pharmacodynamic baseline responses , 2008, Journal of Pharmacokinetics and Pharmacodynamics.

[32]  W. Jusko,et al.  Characterization of four basic models of indirect pharmacodynamic responses , 1996, Journal of Pharmacokinetics and Biopharmaceutics.

[33]  Cheng Hsiao,et al.  Formulation and estimation of dynamic models using panel data , 1982 .